Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbvie, BMS, Compugen, Cytodyn, Dare, Faron, FSD, Gemoab, Kala, Retrophin, Revolution, Terns, Viiv.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Astrazeneca, Biocryst, Grindeks, Hansa, Idera, Kancera, Matinas, Palvella.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Actinium, Arch, Auris, Debiopharm, Dynacure, Psioxus.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alkermes, Allergan, American Brivision, Chugai, Cytodyn, Delmar, Discgenics, Editas, Innovent, Moderna, Oncolys.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Arrowhead, Avita, Bioarctic, CNS, Eisai, Mina, PDC*Line, Neuraly, Prevail, Puretech, Targovax, VBI.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbvie, Albireo, Cytodyn, Evelo, Eyepoint, Galera, GW Pharmaceuticals, Karyopharm, Medivir, Merck, Orthotrophix, Urovant, VBI, Vivus.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Antibe, Biodelivery, Galera, Huya, Ironwood Sorrento.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Advaxis, Anokion, Brainstorm, Clene, Gilead, Incysus, Inflazome, Iteos, Mapkure, Neurimmune, Polypid.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abivax, Actinium, Akcea, Amgen, Apeiron, Bayer, Cyclo, Cytokinetics, Exelixis, Fulcrum, GT Biopharma, Inflarx, Ionctura, Menlo, Oramed, Seelos, Sellas, Servier, Vanda, Zynerba.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Acer, Allecra, Herantis, Ico, IMV, IO Biotech, Marinus, Reneuron, Theralase.